Q4 2022 Holdings
Filed 2023-02-14 | 85 holdings | $4.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Medicus Sciences Acquisition | *W EXP 02/12/202 | G5960S124 | $5.2K | 57,770 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $14.5K | 99,999 | 0.0% |
| Reunion Neuroscience Inc | COM | 76134G103 | $504.3K | 560,300 | 0.0% |
| AC Immune SA(ACIU) | SHS | H00263105 | $663.8K | 325,400 | 0.0% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $879.2K | 37,898 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $961.2K | 31,309 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $1.1M | 104,653 | 0.0% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $1.3M | 1,503,754 | 0.0% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $1.8M | 1,140,600 | 0.0% |
| Social Cap Suvretta Hlds CP | CLASS A ORD SHS | G8253Y105 | $2.0M | 200,000 | 0.0% |
| Social Cap Suvretta Hlds CRP | CLASS A ORD SHS | G8253U103 | $2.0M | 200,000 | 0.0% |
| Caremax Inc | COM CL A | 14171W103 | $2.8M | 755,329 | 0.1% |
| Cyteir Therapeutics Inc | COM | 23284P103 | $3.0M | 1,795,800 | 0.1% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $3.2M | 900,000 | 0.1% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $4.0M | 400,000 | 0.1% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $4.7M | 1,855,400 | 0.1% |
| Panacea Acquisition Corp II | CL A SHS | G6882C106 | $5.0M | 500,000 | 0.1% |
| Arya Sciences Acqu Corp IV | CL A | G31659108 | $5.1M | 500,000 | 0.1% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $5.2M | 1,575,000 | 0.1% |
| Medicus Sciences Acquisition | CL A SHS | G5960S108 | $5.2M | 520,000 | 0.1% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $6.7M | 1,303,600 | 0.1% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $7.1M | 743,600 | 0.2% |
| Kinnate Biopharma Inc | COM | 49705R105 | $7.4M | 1,212,700 | 0.2% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $7.6M | 1,028,200 | 0.2% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $8.6M | 2,748,300 | 0.2% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $10.1M | 2,000,000 | 0.2% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $10.4M | 1,260,000 | 0.2% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $14.5M | 611,000 | 0.3% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $16.4M | 2,057,200 | 0.4% |
| Point Biopharma Global Inc | COM | 730541109 | $17.7M | 2,432,400 | 0.4% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $18.0M | 838,407 | 0.4% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $18.1M | 2,882,600 | 0.4% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $18.5M | 1,126,000 | 0.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $19.3M | 420,700 | 0.4% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $20.7M | 1,492,000 | 0.4% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $21.3M | 1,900,000 | 0.5% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $21.5M | 850,000 | 0.5% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $22.3M | 638,200 | 0.5% |
| Prometheus Biosciences Inc | COM | 74349U108 | $22.4M | 204,000 | 0.5% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $26.0M | 1,755,000 | 0.6% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $26.7M | 504,000 | 0.6% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $29.9M | 1,527,087 | 0.6% |
| Verve Therapeutics Inc | COM | 92539P101 | $30.3M | 1,565,000 | 0.7% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $32.4M | 215,400 | 0.7% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $32.8M | 9,633,911 | 0.7% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $35.0M | 717,300 | 0.8% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $37.8M | 4,599,998 | 0.8% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $38.8M | 92,200 | 0.8% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $40.4M | 258,000 | 0.9% |
| Icon PLC(ICLR) | SHS | G4705A100 | $41.8M | 215,000 | 0.9% |